drugset
drugset / Trial / NCT04608448

Topical-RAPA Use in Inflammation Reversal and Re-setting the Epigenetic Clock

NCT04608448 ↗

Phase 0 Completed 22 enrolled The University of Texas Health Science Center at San Antonio National Institute on Aging (NIA) · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

Topical Rapamycin ointment will be applied to participant forearms to test whether epigenetic changes in the skin are elicited.

Timeline

Start
2021-04-28
Primary completion
2022-04-15
Completion
2022-04-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sirolimus Small molecule 8 % Topical

Indications

No indication recorded.